With biotechnology stock valuations down for more than two years since peaking in February 2021, the industry has gotten somewhat used to volatility, but recent fluctuations paint a clear picture of how sensitive biotech stocks are to major events impacting the sector.
The total value of the global biotechnology sector, defined as pre-commercial therapeutics companies traded on any stock exchange around the...






